A Novel Allosteric Inhibitor Targets PLK1 in Triple Negative Breast Cancer Cells.
Patel JR, Thangavelu P, Terrell RM, Israel B, Sarkar AB, Davidson AM, Zhang K, Khupse R, Tilghman SL. A Novel Allosteric Inhibitor Targets PLK1 in Triple Negative Breast Cancer Cells. Biomolecules. 2022 03 31; 12(4).